NBIX vs OPK · P/E 45, rev $1.77B vs rev $287.8M
Neurocrine Biosciences Inc (NBIX) versus Opko Health Inc (OPK) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Opko Health Inc (OPK) is a diagnostics & research company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported OPK revenue for 2026-06-30 was $287.8M. Net income was -$63.3M. OPK currently screens at market cap $1.07B.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. OPK currently screens at market cap $1.07B.
Not investment advice. Open the NBIX and OPK stock pages for the full models.
Not investment advice.